Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients

Mutations in the cardiac ryanodine receptor (RYR2) are the leading cause for catecholaminergic polymorphic ventricular tachycardia (CPVT). In this study, we evaluated antiarrhythmic efficacy of carvedilol and flecainide in CPVT patient-specific induced pluripotent stem cell-derived cardiomyocytes (i...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. P. Pölönen, K. Penttinen, H. Swan, K. Aalto-Setälä
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2018/9109503
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Postexertional Supraventricular Tachycardia in Children with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Scott D. N. Else, et al.
Published: (2012-01-01)

A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Taishi Fujisawa, et al.
Published: (2019-01-01)

Extracorporeal membrane oxygenation for catecholaminergic polymorphic ventricular tachycardia: a case report and literature review
by: Yuna Li, et al.
Published: (2025-01-01)

The Slower, the Better: Wide Complex Tachycardia Triggered by Flecainide in an Elderly Female
by: Ebubechukwu Ezeh, et al.
Published: (2022-01-01)

Sustained polymorphic ventricular tachycardia in a calf
by: Amir Naseri, et al.

Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
by: Marisa Ojala, et al.
Published: (2016-01-01)

Atrial Tachycardias Arising from Ablation of Atrial Fibrillation: A Proarrhythmic Bump or an Antiarrhythmic Turn?
by: Ashok J. Shah, et al.
Published: (2010-01-01)

Granulomatosis with Polyangiitis with Myocarditis and Ventricular Tachycardia
by: Ramy Magdy Hanna, et al.
Published: (2017-01-01)

Ventricular Tachycardia Induced by Weight Loss Pills
by: Manan Pareek, et al.
Published: (2013-01-01)

Surgical Cryoablation of Drug Resistant Ventricular Tachycardia and Aneurysmectomy of Postinfarction Left Ventricular Aneurysm
by: Marek Pojar, et al.
Published: (2014-01-01)

C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia
by: Aimé Bonny, et al.
Published: (2010-01-01)

Monomorphic Ventricular Tachycardia as a Presentation of Giant Cell Myocarditis
by: Michael H. Chiu, et al.
Published: (2019-01-01)

Right Ventricular Outflow Tract Tachycardia with Structural Abnormalities of the Right Ventricle and Left Ventricular Diverticulum
by: Bortolo Martini, et al.
Published: (2015-01-01)

Case Report: Left ventricular assist device implantation combined with cryoballoon ablation for ventricular tachycardia
by: Shuang Zhang, et al.
Published: (2025-01-01)

Preclinical Evidences for an Antimanic Effect of Carvedilol
by: Greicy Coelho de Souza, et al.
Published: (2015-01-01)

Focal Left Atrial Tachycardia in a Patient with Left Ventricular Noncompaction
by: Shailendra Singh, et al.
Published: (2013-01-01)

Strains of a virtuoso: pacemaker infection and ventricular tachycardia in a violinist
by: Yuanguo Chen, et al.
Published: (2025-01-01)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
by: S. Serge Barold, et al.
Published: (2018-01-01)

Ventricular Tachycardia Originating from Moderator Band: New Perspective on Catheter Ablation
by: Jin-yi Li, et al.
Published: (2017-01-01)

Relevance of Chronic Total Occlusion for Outcome of Ventricular Tachycardia Ablation in Ischemic Cardiomyopathy
by: Julia Anna Lurz, et al.
Published: (2022-01-01)

Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
by: Yusi Yao, et al.
Published: (2020-01-01)

Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease
by: Sheng Su, et al.
Published: (2025-01-01)

First Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy Showing Refractory Ventricular Tachycardia Induced by Thyroid Storm due to Graves’ Disease
by: Masaki Matsubara, et al.
Published: (2022-01-01)

Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction
by: M. V. Fadeeva, et al.
Published: (2019-06-01)

Expression of catecholaminergic genes in the midbrain and prepulse inhibition in rats with a genetic catatonia
by: M. A. Ryazanova, et al.
Published: (2017-12-01)

Morphometric Analysis of Human Embryonic Stem Cell-Derived Ventricular Cardiomyocytes: Determining the Maturation State of a Population by Quantifying Parameters in Individual Cells
by: Harvey Y. S. Chan, et al.
Published: (2015-01-01)

Ventricular Tachycardia Possibly Originated From the His‐Purkinje System May Result From Aconitine Poisoning
by: Honglin Ni, et al.
Published: (2025-01-01)

Cryoablation for Ventricular Tachycardia Originating from Anterior Papillary Muscle of Left Ventricle Guided by Intracardiac Echocardiography
by: Ibrahim Marai, et al.
Published: (2017-01-01)

Retraction: Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis.
by: PLOS One Editors
Published: (2025-01-01)

Cardiac Tamponade Due to Right Ventricle Perforation: A Rare Complication of Catheter Ablation for Ventricular Tachycardia Storm
by: Annisa Puspitasari Nachrowi, et al.
Published: (2024-10-01)

Predictors of recurrence of ventricular tachycardia and the effectiveness of endocardial ablation at the patients with sudden cardiac death and history of myocardial infarction
by: O. M. Grytsay, et al.
Published: (2024-11-01)

Nanoplastics induces arrhythmia in human stem-cells derived cardiomyocytes
by: Shirley Pei Shan Chia, et al.
Published: (2025-01-01)

How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease
by: Andrew Ramadeen, et al.
Published: (2012-01-01)

Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy
by: John G. Pagiazitis, et al.
Published: (2025-01-01)

Oral delivery of the non-β-blocking R-carvedilol enantiomer for skin cancer chemoprevention in SKH-1 mice
by: Pabitra K. Sardar, et al.
Published: (2025-01-01)

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
by: Nicolas De Schryver, et al.
Published: (2019-01-01)

Cost-effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy for the Treatment of Atrial Fibrillation: A Canadian Perspective
by: Yaariv Khaykin, et al.
Published: (2016-10-01)

Selective Laser Sintering 3D Printing of Carvedilol Tablets: Enhancing Dissolution Through Amorphization
by: Nikola Pešić, et al.
Published: (2024-12-01)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Zhihan Zhao, et al.
Published: (2018-01-01)

Extracellular Recordings of Patterned Human Pluripotent Stem Cell-Derived Cardiomyocytes on Aligned Fibers
by: Junjun Li, et al.
Published: (2016-01-01)